Omada Health (NASDAQ:OMDA) CFO Sells $27,700.00 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 1,108 shares of the firm’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $25.00, for a total value of $27,700.00. Following the sale, the chief financial officer owned 187,209 shares in the company, valued at $4,680,225. This trade represents a 0.59% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Omada Health Trading Up 2.1%

Omada Health stock opened at $23.31 on Thursday. The firm has a market capitalization of $1.43 billion, a P/E ratio of 466.20 and a beta of 1.86. The stock has a fifty day moving average price of $22.59 and a 200 day moving average price of $17.46. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. The firm had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. Omada Health had a return on equity of 2.60% and a net margin of 1.39%. As a group, equities analysts predict that Omada Health, Inc. will post 0.09 EPS for the current year.

Institutional Trading of Omada Health

A number of institutional investors have recently modified their holdings of the company. Geode Capital Management LLC acquired a new stake in Omada Health during the 2nd quarter worth approximately $637,000. Walleye Capital LLC purchased a new position in Omada Health in the second quarter valued at approximately $458,000. Ilex Capital Partners UK LLP acquired a new position in Omada Health during the second quarter valued at approximately $201,000. Soros Fund Management LLC acquired a new position in Omada Health during the second quarter valued at approximately $640,000. Finally, Raymond James Financial Inc. purchased a new stake in Omada Health during the second quarter worth approximately $32,000.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Wells Fargo & Company raised their target price on shares of Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Needham & Company LLC reaffirmed a “buy” rating and set a $28.00 price target on shares of Omada Health in a research report on Friday, May 8th. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a research note on Friday, August 14th. Canaccord Genuity Group boosted their price objective on shares of Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a research note on Tuesday, July 21st. Finally, Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Eleven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $26.50.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.